3:25-cv-19038 ABBVIE INC. et al v. MACLEODS PHARMACEUTICAL LTD. et al
Answer to Counterclaim ( 33
ABBVIE INC. et al v. MACLEODS PHARMACEUTICAL LTD. et al is a civil case with a current summary of Answer to Counterclaim (33. The case involves the defendants, ABBVIE INC. et al, who have filed an answer to the counterclaim of the plaintiffs, MACLEODS PHARMACEUTICAL LTD. et al. The answer indicates that the defendants are responding to the counterclaim and will present their arguments and evidence in support of their position. The exact details of the case and the defendants' arguments are not specified in the available information.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Court
D.N.J.
District of New Jersey · 3rd Circuit · NJ
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
3:25-cv-19038 ABBVIE INC. et al v. MACLEODS PHARMACEUTICAL LTD. et al
Other · Apr 24, 2026
Coverage
1 article
1 source tracked
Participants
1 Defendant
2 linked entities
Judge
Not assigned in feed
This case is tied to District of New Jersey, a federal district court in NJ.
The newest docket activity we have is a other dated April 24, 2026.
The visible party/entity graph currently includes MACLEODS PHARMACEUTICAL LTD and others.
Press monitoring has found 1 related article from 1 distinct source.
ABBVIE INC. et al v. MACLEODS PHARMACEUTICAL LTD. et al is an active civil matter in District of New Jersey under docket 25-cv-19038.
The dispute currently identifies 3:25-cv-19038 ABBVIE INC on one side and MACLEODS PHARMACEUTICAL LTD on the other. The case is currently organized around Answer to counterclaim, Defendants' arguments, Court's decision.
et al is a civil case with a current summary of Answer to Counterclaim (33. The case involves the defendants, ABBVIE INC. et al, who have filed an answer to the counterclaim of the plaintiffs, MACLEODS PHARMACEUTICAL LTD.
et al. The answer indicates that the defendants are responding to the counterclaim and will present their arguments and evidence in support of their position. The exact details of the case and the defendants' arguments are not specified in the available information.
On April 24, 2026, the docket recorded a other: Abbvie Inc. and others filed an answer to the counterclaim in the ongoing lawsuit against Macleods Pharmaceutical Ltd. and others.
The counterclaim was likely filed in response to Abbvie's original lawsuit. This development indicates that the parties are.
The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.
District of New Jersey (D.N.J.) is a federal district court in the 3rd Circuit, NJ.
Abbvie Inc. and others filed an answer to the counterclaim in the ongoing lawsuit against Macleods Pharmaceutical Ltd. and others. The counterclaim was likely filed in response to Abbvie's original lawsuit. This development indicates that the parties are continuing to engage in the litigation process.
Answer to Counterclaim ( 33
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
2 days, 14 hours ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.